Clinical

All articles by Clinical

The FDA’s upcoming clinical research revamp
The FDA’s upcoming clinical research revamp
Lecia Bushak
November 29, 2021
12:00 pm

Here’s what a restructuring of clinical trials might look like under FDA commissioner pick Dr. Robert Califf.

Sundeep Bhan, Prognos
Sundeep Bhan, Prognos
May 1, 2018
12:00 pm

Sundeep Bhan is cofounder and CEO of Prognos.

Ortho CEO leads massive turnaround
Ortho CEO leads massive turnaround
Larry Dobrow
March 7, 2018
10:00 am

When Ortho Clinical Diagnostics lived under the roof of Johnson & Johnson, it had the luxury of focusing on its product and service mix — and not a whole lot else.

Five things for pharma marketers to know: Friday, December 8, 2017
Five things for pharma marketers to know: Friday, December 8, 2017
Virginia Lau
December 8, 2017
3:20 pm

FDA approves first nebulized LAMA COPD treatment; more than 2,000 cancer immunotherapies in development; FDA issues 3D-printing guidance

Five things for pharma marketers to know: Thursday, November 16, 2017
Five things for pharma marketers to know: Thursday, November 16, 2017
Virginia Lau
November 16, 2017
3:20 pm

Docs biased against research from poor countries, study finds; Astellas probed over patient-assistance charity support; Acorda reports deaths in Parkinson’s trial

Five things for pharma marketers to know: Monday, November 13, 2017
Five things for pharma marketers to know: Monday, November 13, 2017
Virginia Lau
November 13, 2017
3:15 pm

Dynavax receives FDA approval for hepatitis-B vaccine; Novartis strikes R&D deal with gene-editing startup; White House nominates new HHS head

Can marketing techniques save clinical trials?
Can marketing techniques save clinical trials?
Larry Dobrow
September 5, 2017
11:00 am

No crucial area in pharma is more desperately in need of a fix — or more stubbornly resistant to change.

Five things for pharma marketers to know: Monday, July 31, 2017
Five things for pharma marketers to know: Monday, July 31, 2017
Virginia Lau
July 31, 2017
2:35 pm

FDA launches digital health pre-certification pilot; J&J’s experimental RA drug raises safety concerns; AstraZeneca gets breakthrough status for Imfinzi

Five things for pharma marketers to know: Thursday, July 6, 2017
Five things for pharma marketers to know: Thursday, July 6, 2017
Virginia Lau
July 6, 2017
2:20 pm

The FDA suspends three Keytruda studies; drug and device makers gave $8 billion in payments to providers in 2016; Opdivo beat Yervoy in skin-cancer trial

Five things for pharma marketers to know: Monday, April 10, 2017
Five things for pharma marketers to know: Monday, April 10, 2017
Virginia Lau
April 10, 2017
2:50 pm

Gilead receives approval to market Harvoni, Sovaldi to adolescents; OncoMed ends mid-stage trials for pancreatic cancer drug; researchers use facial recognition software to diagnose

  • From Our Partners